Naturex Sa

Naturex

Université D'avignon Et Des Pays De Vaucluse

Avignon Université

Givaudan France Naturals Sas

Universite D'avignon Et Des Pay De Vaucluse

Givaudan France Naturals

Marc Roller

Antoine Charles Bily

Simona Birtic

Jacques Dikansky

Alvin Ibarra

Kan He

Farid Chemat

Naisheng Bai

Nicolas Feuillere

Leila Denise Falcao

Anne-Sylvie Fabiano Tixier

Karl Chevalier

Anne Sylvie Fabiano Tixier

Andrew Scholey

Alexis Lavaud

Lise Laurençon

Marjolaine Meyer

Anne Passemard

Xavier Pierre François Mesnier

François-Xavier Henri Pierre

Natacha Rombaut

Michael Laguerre

Melanie Marie-Paule Heudre

Francois-Xavier Henri Pierre

Xavier Pierre Mesnier

Pascale Elizabeth Renée Fanca-berthon

Michaël Laguerre

Pascale Elizabeth Renée Fança-Berthon

Sophie Lafay

Benoit Lemaire

Romain Lecozannet

Matthieu Tenon

Mélanie Marie-Paule Patricia Heudré

Mélanie Marie-Paule Patricia Heudre

Pascale Elizabeth Fanca-Berthon

Pascale Elizabeth Renée Fanca-Berthon

Pascale Elizabeth Renée FANÇA-Berthon

Melanie Marie-Paule Patricia Heudre

Antoine Bily

A eutectic extraction solvent for extracting plant (e.g. vegetable) and/or animal and/or prokaryotic biological material, wherein the solvent is a clear, stable and fluid mixture comprising:

Eutectic extraction solvents, extraction methods by eutectigenesis using said solvents, and extracts derived from said extraction methods

The present invention relates to extracts fromsamara, processes for providing such extracts, and methods and uses of the extracts obtained. In particular, the present invention relates to the use of such extracts in reversing obesity-related and/or metabolic syndrome-related gut microbiota dysbiosis treatment, treating or preventing hepatic steatosis, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), and modulating and/or adjusting gut microbiota.

Therapeutic use of a Fraximus augustifolia extract

The present invention relates to an extract obtained from or obtainable from, a composition comprising an extract obtained from or obtainable from, processes for providing such an extract, and methods and uses relating to such extracts. In particular, the present invention relates to an extract or composition for use in treating or preventing inflammation, such as arthritis and joint inflammation.

Method for treating or preventing inflammation

A eutectic extraction solvent for extracting plant (e.g. vegetable) and/or animal and/or prokaryotic biological material, wherein the solvent is a clear, stable and fluid mixture comprising: (a) betaine or a hydrated form of betaine; (b) at least one hydrogen bond donor compound selected from the group consisting of polyols and organic acids; and (c) water with the proviso that the eutectic extraction solvent does not contain any exogenous sugar and/or amine salt and/or anion.

The invention relates to a novel organic solubilisation and/or extraction solvent comprising at least one compound selected from the group of saturated monocyclic terpenoids, to an extraction method using said solvent, and to extracts obtained by said method. More particularly, the invention relates to a novel use of para-menthane, a saturated terpenoid compound, as a solvent derived from natural substances, and also to a solvent comprising para-menthane.

Organic solubilisation and/or extraction solvent, extraction method using said solvent, and extracts obtained by said method

A composition includes hesperdin and/or a Lamiaceae extract wherein a majority of the volatile components have been removed from the Lamiaceae extract. A method for applying the composition to a food such as meat, fish or poultry, including processed and fresh or unprocessed meat, poultry and fish is also provided.

Antimicrobial compositions

A composition for improving muscle metabolism in a subject and methods for manufacturing and using same. Embodiments include compositions having an extract ofand an extract of. An extract ofmay include amounts of ecdysterones including 20-hydroxyecdysone. An extract ofmy include salidrosides and rosavins, including rosavin. Suitable ingestion dosages of the composition may be operable to increase protein synthesis and reduce protein proteolysis in a subject.

Compositions and methods for improved muscle metabolism

A composition includesextract and a Lamiaceae extract, wherein a majority of the volatile oil components have been removed from the Lamiaceae extract. A method for applying the composition to a food which includes but is not limited to fresh/unprocessed and processed meat, fish or poultry is also provided.

A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 4-caffeoylquinic acid (4-CQA) to total chlorogenic acids (tCGA) (5-CQA/tCGA) of from about 0.1 to about 0.2. More preferably, the green coffee extract comprises from about 6% to about 8% of 4-caffeoylquinic acid and has a total chlorogenic acid concentration that exceeds about 45%. A preferred method of administration consists of administering the green coffee extracts is a dosage of about 200 mg twice a day prior to meals on an empty stomach.

Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolism

Disclosed are methods of enhancing neurocognitive function by administering of American. Preferred dosages in the range of 5 to 50 mg total ginsenosides enhance cognitive function&#x2014;including, improvement of working memory (WM) performance, attentional performance (e.g., Choice Reaction Time accuracy), and calmness.

Application of American Ginseng to enhance neurocognitive function

Disclosed are methods of alleviating oxidative stress, regulating blood glucose levels, and controlling pancreatic lipase activity by administering a Rosemary extract. Such methods may be useful to help body weight and body fat, prevent obesity, and treat hyperglycemia, hyperinsulinemia, cardiovascular disease and Type-2 diabetes. Preferred extracts contain 20% or 50% carnosic acid.

[object Object]

A method of enhancing physical performance during exercise by administering an amount of a grape extract effective to treat a subject. A preferred grape extract comprises a concentration of flavanol monomers of greater than about 5% by weight, and more preferably within a range from about 12% by weight to about 50% by weight, and a concentration of flavanol dimers preferably greater than about 2% by weight, and more preferably within a range from about 6% by weight to about 20% by weight. The flavanol monomers preferably include catechin, epicatechin, epicatechin gallate, and gallic acid. The flavanol dimers preferably include procyanidin B1, procyanidin B2, procyanidin B3, procyanidin B4, and procyanidin B2-O-gallate.

Antioxidant and physical performance effects of a grape extract

Growing community of inventors

Morieres les Avignon, France

Marc Roller